Evaluation of cytokine modulators for asthma

Chung, 1999, Cytokines in asthma, Thorax, 54, 825, 10.1136/thx.54.9.825 Barnes, 2001, Cytokine-directed therapies for asthma, J Allergy Clin Immunol, 108, S72, 10.1067/mai.2001.116435 Kay, 2001, Allergy and allergic diseases. First of two parts, N Engl J Med, 344, 30, 10.1056/NEJM200101043440106 Elias, 1999, Airway remodeling in asthma, J Clin Invest, 104, 1001, 10.1172/JCI8124 Yamaya, 1995, Down-regulation of Th2 cell-mediated murine peritoneal eosinophilia by antiallergic agents, Life Sci, 56, 1647, 10.1016/0024-3205(95)00132-P Tamaoki, 2000, Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study, Lancet, 356, 273, 10.1016/S0140-6736(00)02501-0 Dent, 1994, Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol, J Pharmacol Exp Ther, 271, 1167 Torphy, 1998, Phosphodiesterase isozymes: molecular targets for novel antiasthma agents, Am J Respir Crit Care Med, 157, 351, 10.1164/ajrccm.157.2.9708012 Markham, 1998, Theophylline — A review of its potential steroid sparing effects in asthma, Drugs, 56, 1081, 10.2165/00003495-199856060-00018 Harbinson, 1997, The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects, Eur Respir J, 10, 1008, 10.1183/09031936.97.10051008 Borish, 2001, Efficacy of soluble IL-4 receptor for the treatment of adults with asthma, J Allergy Clin Immunol, 107, 963, 10.1067/mai.2001.115624 Leckie, 2000, Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response, Lancet, 356, 2144, 10.1016/S0140-6736(00)03496-6 O'Byrne, 2001, The trials and tribulations of IL-5, eosinophils, and allergic asthma, J Allergy Clin Immunol, 108, 503, 10.1067/mai.2001.119149 van der Pouw Kraan, 1997, Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma, J Immunol, 158, 5560, 10.4049/jimmunol.158.11.5560 Schwartz, 2002, A new element in the mechanism of asthma, N Engl J Med, 346, 857, 10.1056/NEJM200203143461114 Bryan, 2000, Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response, Lancet, 356, 2149, 10.1016/S0140-6736(00)03497-8 Vogel, 1997, New clues to asthma therapies, Science, 276, 1643, 10.1126/science.276.5319.1643 Sano, 2003, Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma, J Allergy Clin Immunol, 111, 958, 10.1067/mai.2003.1415 Tamaoki, 2003, A Th2 cytokine inhibitor for airway inflammation in mild asthma (letter), J Allergy Clin Immunol, 111, 197, 10.1067/mai.2000.318 Flood-Page, 2003, Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway, Am J Respir Crit Care Med, 167, 199, 10.1164/rccm.200208-789OC Kips, 2003, Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma — a pilot study, Am J Respir Crit Care Med, 167, 1655, 10.1164/rccm.200206-525OC